Olema Pharmaceuticals $100 million at-the-market offering
The shares are listed on the Nasdaq Global Select Market
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Integral Ad Science $165.6 million secondary offering
The stock is listed on the Nasdaq Global Market
Hayward Holdings $286 million secondary offering
The stock is listed on the New York Stock Exchange
Beyond Meat $200 million at-the-market offering
The stock offering is SEC-registered
Privia Health Group $936 million secondary offering
We advised Privia on the registered secondary offering
PGE $300 million at-the-market offering
The common stock is listed on the NYSE
IDEAYA Biosciences $201 million equity offering
The common stock is listed on the Nasdaq Global Select Market
Diagnósticos da América R$1.7 billion equity offering
The common shares and the warrants are listed on the São Paulo Stock Exchange
Gamida Cell $23 million follow-on offering
The shares are listed on the Nasdaq Global Select Market
AN2 Therapeutics $100 million at-the-market offering
The shares are listed on the Nasdaq Global Select Market